Insider trades
Paul F. Lizzul, Chief Officer of First Tracks Biotherapeutics TRAX, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $521.5K. The latest trade was on 05/12.
Paul F. Lizzul
Chief Medical Officer
- First filing
- 23/01/10
- Trades
- 58 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$521.5K
- Last trade
- 05/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AnaptysbioANAB | Open-market sale | 01/08 | 01/09 | 3,650 sh | $44.71 | $163,191.5 | −8.0% |
AnaptysbioANAB | Open-market sale | 01/07 | 01/08 | 2,235 sh | $45.11 | $100,820.85 | −5.7% |
AnaptysbioANAB | Open-market sale | 01/05 | 01/06 | 4,219 sh | $43.26 | $182,513.94 | −11.2% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 25/12/22 | 25/12/23 | 1,500 sh | $50.00 | $75,000 | −5.3% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 24/09/23 | 24/09/24 | 1,500 sh | $38.67 | $58,005 | −8.9% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 24/09/16 | 24/09/17 | 2,220 sh | $38.93 | $86,424.6 | −12.6% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 24/08/14 | 24/08/16 | 2,000 sh | $40.00 | $80,000 | −14.7% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 24/07/18 | 24/07/19 | 1,500 sh | $35.00 | $52,500 | −11.4% |
AnaptysbioANAB | Open-market sale | 24/01/08 | 24/01/09 | 2,554 sh | $21.81 | $55,702.74 | −20.2% |
AnaptysbioANAB | Open-market sale | 23/09/14 | 23/09/18 | 2,105 sh | $19.48 | $41,005.4 | −24.4% |
